Lung Neoplasm Malignant
23
8
9
6
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
13.0%
3 terminated out of 23 trials
66.7%
-19.9% vs benchmark
9%
2 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (23)
A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)
Self-Management Support for Lung Cancer Patients With Cachexia
Enhanced COPD Management in Suspected Lung Cancer Patients
Benefit of Spectral Information in Patients Suspected for Lung Cancer
Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid Tumors
Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors
Aliya™ Pulsed Electric Fields (PEF) for Advanced Cancer
Confocal Laser Endomicroscopy VERification
(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations
Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer
MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer
Broadband Collaborative Pulse Ablation Instrument Treating Malignant Pulmonary Nodules
Feasibility of an Activity Regimen in Patients With Advanced Stage Lung Cancer
Feasibility Trial of a Personalised Nutrition and Activity Programme for People With Lung Cancer Over 65 Years
Coorticosteroid Regimen in Patients With Anti-PD-1/PD-L1 Induced Pneumonitis
Evaluation of Blood TMB for the Efficacy of Atezolizumab [BUDDY]
Resistance Inspiratory Muscle Training for Patients With Thoracic Malignancies
Beneficial Effect of Pulmonary Rehabilitation in Lung Cancer Patients Receiving Radiation Therapy
Prognostic Value of the 6-minute Stepper Test in Non-small Cell Lung Cancer Surgery